Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
drugs
3
×
fda
3
×
indiana blog main
indiana top stories
life sciences
national blog main
teva pharmaceutical
3
×
amgen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
detroit blog main
detroit top stories
eli lilly
migraine
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acute myeloid leukemia
alder biopharmaceutical
allergan
american academy of neurology
american society of clinical oncology
What
fda
3
×
approval
class
drug
drugs
migraine
new
won
ahead
announced
approved
arguments
asco
big
bio
branded
choices
commercialized
commissioner
companies
competitors
consumers
costly
counterweight
decades
decision
developed
elevatebio
eli
generic
graft
headache
late
lilly
make
marks
medications
medicines
meeting
neuro
Language
Current search:
fda
×
drugs
×
fda
×
" teva pharmaceutical "
×
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
